MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response

MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response

Myelodysplastic syndromes (MDS) are a group of malignant clonal hematological disorders with heterogeneous clinical course and risk of transformation to acute myeloid leukemia. Genetic and epigenetic dysregulation, including alterations in microRNA (miRNA) expression, plays a pivotal role in MDS pat...

Full description

Bibliographic Details
Main Authors: Ilina Dimitrova Micheva, Svilena Angelova Atanasova
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-08-01
Series:Frontiers in Oncology
Subjects:
myelodysplastic syndromes
microRNA
diagnostic and prognostic biomarkers
therapeutic microRNAs
circulating microRNA
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1410656/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1410656/full

Similar Items